[Apoptosis of human leukemic cells induced by topoisomerase I and II inhibitors]. / Apoptose des cellules leucémiques humaines induite par les inhibiteurs de topo-isomérase I et II.
Bull Cancer
; 83(3): 205-12, 1996 Mar.
Article
em Fr
| MEDLINE
| ID: mdl-8695922
ABSTRACT
Comparison between five human leukemic lines (BV173, HL60, U937, K562, KCL22) suggest that the main determinant of their sensitivity to topoisomerase I (camptothecin) and II (VP-16) inhibitors is their ability to regulate cell cycle progression in response to specific DNA damage, then to die through apoptosis the more the cells inhibit cell cycle progression, the less sensitive they are. The final pathway of apoptosis induction involves a cytoplasmic signal, active at neutral pH, needing magnesium, sensitive to various protease inhibitors and activated directly by staurosporine. Modulators of intracellular signaling (calcium chelators, calmodulin inhibitors, PKC modulators, kinase and phosphatase inhibitors) have no significant influence upon apoptosis induction. Conversely, apoptosis induction pathway is modified during monocytic differentiation of HL60 cells induced by phorbol esters. Lastly, poly(ADP-ribosyl)ation and chromatine structure should regulate apoptotic DNA fragmentation that is prevented by 3-aminobenzamide and spermine, respectively.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Leucemia
/
Apoptose
/
Inibidores da Topoisomerase I
/
Inibidores da Topoisomerase II
Limite:
Humans
Idioma:
Fr
Revista:
Bull Cancer
Ano de publicação:
1996
Tipo de documento:
Article
País de afiliação:
França